Selective JAK1 Inhibition with Itacitinib Enhances Haploidentical Transplantation Outcomes by Mitigating GvHD and CRS – Medicine Innovates Share LinkedIn
Medicine Innovates Medicine Innovates: Delivering innovations in medicine to the world for better health and prosperity
